Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$8.8MFederal grants as PI11 awards
0Patents grantedNone matched
44Papers506 citations
Federal awards and patents by year
AwardsPatents
11 awards · $8.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 30, 2024 | NIH | SBIR Phase II Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | $997K | Triangle Biotechnology, Inc. |
| Sep 30, 2023 | NIH | SBIR Phase I Culture-free microbial enrichment for diagnosis and characterization of anti-microbial resistance | $300K | Triangle Biotechnology, Inc. |
| Aug 31, 2023 | NIH | SBIR Phase I SBIR PA22-176 - Culture-free microbial enrichment for diagnosis and characterization of anti-microbial resistance | $300K | Triangle Biotechnology, Inc. |
| Apr 6, 2023 | NIH | SBIR Phase II Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | $998K | Triangle Biotechnology, Inc. |
| May 25, 2022 | NIH | SBIR Phase II Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | $2.0M | Triangle Biotechnology, Inc. |
| Jul 30, 2021 | NIH | SBIR Phase II Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | $1.2M | Triangle Biotechnology, Inc. |
| Sep 8, 2020 | NIH | SBIR Phase II Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | $2.0M | Triangle Biotechnology, Inc. |
| Aug 3, 2020 | NIH | SBIR Phase I Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology | $252K | Triangle Biotechnology, Inc. |
| Feb 1, 2020 | NSF | SBIR Phase I SBIR Phase I: Design of custom ultrasonic lens for uniform sonication of biological samples in microplates | $225K | Triangle Biotechnology, Inc. |
| Apr 9, 2019 | NIH | SBIR Phase I SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples | $299K | Triangle Biotechnology, Inc. |
| Jul 5, 2018 | NIH | SBIR Phase I Towards commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications | $299K | Triangle Biotechnology, Inc. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#96
Awards as PI#114
Patents#505
Companies
- Triangle Biotechnology, Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.